Stock Events

Stock Events

Mersana Therapeutics (MRSN) Q2 2023 Earnings

8AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.61

-0.44

-0.26

-0.09

Details

Expected EPS

-0.5

Actual EPS

-0.47

Surprise EPS

0.03

Surprise Percent

+6%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.47 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.